Faes Farma SA
Common Stock · EUR · BME
Price
€4.738
Cap
€1.05B
Earnings
—
30d Trend
-1.4%
24% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 58×Macro 0.99 (−1%)=57
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
12-24 month value thesis — fundamentally underpriced
BRAIN47'S ASSESSMENT
I rate Faes Farma SA at 57/100 — a STRONG reading on the Brain47 Signal. The strongest factor is risk management at 70/100. I classify this as a income position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
-0.5%
3 MONTHS
-8.4%
12 MONTHS
+14.1%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
12-24 month value thesis — fundamentally underpriced. low-risk profile and Fundamentals (65) are the primary strengths. Historical volatility is normal at 24%. I classify this as an income position — the 3.7% yield combined with the dividend profile makes it suitable for income generation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.